Bicara Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 7.26 M | $215.43 M | 0.00% | 10.68% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 6.34 M | $188.19 M | -4.05% | 9.33% |
| SIREN, L.L.C. | 08/13/2026 | 5.60 M | $166.35 M | -3.45% | 8.25% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 5.25 M | $155.87 M | -3.23% | 7.73% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 4.10 M | $121.73 M | 0.92% | 6.04% |
| BLACKROCK, INC. | 08/07/2026 | 3.85 M | $114.25 M | 35.32% | 5.67% |
| JUPITER TOPCO LLC | 08/14/2026 | 3.17 M | $93.96 M | 100.00% | 4.67% |
| RED TREE MANAGEMENT, LLC | 07/22/2026 | 3.16 M | $93.92 M | -0.22% | 4.66% |
| TPG GP A, LLC | 08/14/2026 | 3.01 M | $89.38 M | 0.00% | 4.43% |
| ROYALTY PHARMA SUB-MANAGER, LLC | 08/14/2026 | 2.39 M | $60.61 M | 0.00% | 3.52% |
| STATE STREET CORP | 09/22/2026 | 2.05 M | $60.83 M | 44.35% | 3.37% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.22 M | $65.81 M | 24.94% | 3.26% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.95 M | $57.95 M | 20.37% | 2.87% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.90 M | $56.54 M | 38.37% | 2.80% |
| FMR LLC | 08/13/2026 | 1.89 M | $56.21 M | -9.89% | 2.79% |
| OMEGA FUND MANAGEMENT, LLC | 08/14/2026 | 1.82 M | $54.10 M | -23.83% | 2.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.16 M | $34.53 M | 39.92% | 1.71% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.02 M | $29.81 M | 472.67% | 1.50% |
| JONES HILL CAPITAL LP | 08/13/2026 | 892.62 K | $26.50 M | -29.16% | 1.31% |
| ACORN CAPITAL ADVISORS, LLC | 08/14/2026 | 643.38 K | $19.10 M | 0.00% | 0.95% |
| AISLING CAPITAL MANAGEMENT LP | 08/13/2026 | 568.92 K | $16.89 M | 0.00% | 0.84% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 550.41 K | $16.34 M | 0.00% | 0.81% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 535.29 K | $15.89 M | 9.44% | 0.79% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 520.57 K | $15.46 M | -6.87% | 0.77% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 498.19 K | $14.79 M | 79.89% | 0.73% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 461.72 K | $13.71 M | 322.59% | 0.68% |
| NAN FUNG TRINITY (HK) LTD | 07/24/2026 | 427.89 K | $12.70 M | 0.00% | 0.63% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 418.91 K | $12.44 M | 43.99% | 0.62% |
| NORTHERN TRUST CORP | 08/13/2026 | 396.34 K | $11.77 M | 55.08% | 0.58% |
| CANDRIAM S.C.A. | 08/13/2026 | 373.38 K | $11.07 M | 56.34% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 365.48 K | $10.85 M | 38.45% | 0.54% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 365.48 K | $10.85 M | 100.00% | 0.54% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 353.23 K | $10.49 M | 227.04% | 0.52% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 352.90 K | $10.48 M | 7.60% | 0.52% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 342.21 K | $10.16 M | -14.76% | 0.50% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 313.74 K | $9.31 M | 44.74% | 0.46% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 289.79 K | $8.60 M | 0.20% | 0.43% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 288.75 K | $8.57 M | 1,725.45% | 0.43% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 284.96 K | $8.46 M | -32.43% | 0.42% |
| MORGAN STANLEY | 08/13/2026 | 283.88 K | $8.43 M | -32.60% | 0.42% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 262.25 K | $7.79 M | 67.36% | 0.39% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 261.12 K | $7.75 M | -3.19% | 0.38% |
| ALGERT GLOBAL LLC | 08/13/2026 | 233.23 K | $6.92 M | -29.50% | 0.34% |
| WOODLINE PARTNERS LP | 08/14/2026 | 232.69 K | $6.91 M | 0.00% | 0.34% |
| SEB ASSET MANAGEMENT AB | 08/04/2026 | 232.16 K | $6.89 M | 100.00% | 0.34% |
| CITADEL ADVISORS LLC | 09/02/2026 | 211.14 K | $6.27 M | -87.28% | 0.31% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 191.10 K | $5.67 M | -71.36% | 0.28% |
| HEALTHINVEST PARTNERS AB | 07/24/2026 | 145.66 K | $4.32 M | -87.55% | 0.21% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 144.01 K | $4.28 M | 9.38% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 120.67 K | $3.58 M | 44.92% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bicara Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 196 institutional investors and hedge funds held shares of Bicara Therapeutics Inc.. The most heavily invested institutionals were:
Versant Capital Management, Inc: 434
RA CAPITAL MANAGEMENT, L.P.: 7.26 M
T. Rowe Price Investment Management, Inc.: 6.34 M
Siren, L.L.C.: 5.6 M
Vestal Point Capital, LP: 5.25 M
Deep Track Capital, LP: 4.1 M
119.50% of Bicara Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 78.24 M shares in the last 24 months. This purchase volume represents approximately $1.54 B in transactions.